Myasthenia gravis trials in Saudi Arabia

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Taking people
  KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

  Where

  Riyadh

  Age

  18 years to 75 years

  People

  66 worldwide

  Run by

  Kyverna Therapeutics

  See details and how to joinNCT06193889 · EU 2023-509892-17-00
• No phaseTaking people
  Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

  Where

  Abhā, Jeddah, Riyadh

  Age

  18 years and over

  People

  500 worldwide

  Run by

  Alexion Pharmaceuticals, Inc.

  See details and how to joinNCT04202341